Nancy Levin

Background

About Nancy Levin

Successful drug discovery scientific research leader with a proven track record in small private and public biotechs and large pharma. Nonclinical development experience in large and small molecules (across multiple therapeutic modalities including proteins, peptides, antibody-drug and antibody-peptide conjugates, and small molecules), including preclinical pharmacology and IND-enabling PK/AMDE and safety for multiple therapeutic indications including oncology, metabolic disease, CNS, dermatology. Focus on triage, acceleration and delivery of preclinical candidates with depth and scope to realize clinical success and significant return on investment; capital efficient asset development to accelerate the delivery of high value preclinical packages resulting in important new clinical candidates, with particular focus on critical PK/PD and translational pharmacology to ensure differentiated target product profiles. Breadth of drug discovery and development expertise from target validation through early clinical development and clinical proof-of-concept. Experienced in the construction of competitive and strategic research portfolios utilizing in-house expertise and external alliances. Adept evaluation of novel therapeutic approaches including competitive landscape and market opportunity. Results-driven, tactical and pragmatic decision maker, with extensive leadership experience to build, lead, and mentor high functioning teams. Clear and effective communicator with basic and clinical scientists as well as regulatory and commercial colleagues.